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A rare cause of congenital portosystemic shunt: type 2 abernethy malformation 
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Abstract 
The Abernethy malformation is characterized by congenital extrahepatic portosystemic shunts 
and is divided into two groups according to the type of anastomosis. In type 1, all portal 
venous blood is discharged into the inferior vena cava and there is no intrahepatic portal vein. 
In type 2, the portal vein is partially discharged to the inferior vena cava via side-by-side 
anastomoses. Imaging has an important role in the diagnosis and follow-up of this 
malformation. Magnetic resonance imaging should be preferred to demonstrate both vessel 
anatomy and associated anomalies. The aim of this study was to present a 17-year old male 
patient and to discuss the imaging findings of Abernethy malformation. 
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INTRODUCTION 
The Abernethy malformation was first reported by John Abernethy in 1793 and is 
characterized by the removal of portal venous blood from the liver by end-to-end and side-to-
side shunts [1]. Approximately 80% of cases are children aged <18 years. Complications such 
as hepatic encephalopathy and hepatopulmonary syndrome may develop in patients. It is 
divided into two classes according to the type of anastomosis between the portal vein (PV) 
and the inferior vena cava (IVC) and the presence of intrahepatic portal vein supply. In 
Abernethy malformation type 1, all of the portal venous supply is discharged into the inferior 
vena cava and there is no intrahepatic PV. In type 2, the portal vein is partially discharged into 
the IVC via side-by-side anastomoses [2].  
Imaging has an important role in the diagnosis and follow-up of this malformation. 
Magnetic resonance imaging (MRI) should be preferred to demonstrate both vessel anatomy 
and associated anomalies [3]. The aim of this study was to present a 17-year old male patient 
and to discuss the imaging findings of Abernethy malformation. 
 
CASE REPORT 
A 17-year old male was admitted to our hospital with complaints of abdominal pain, 
vomiting and mental fog, which had been ongoing for 3 days. There was no history of fever, 
abdominal trauma, weight loss or jaundice, and there had been no similar episode in the past. 
The family history showed no gastrointestinal cancer. There was mild epigastric tenderness on 
physical examination. There was no abnormality in the complete blood count. The serum 
CRP, sedimentation, ALT, AST, GGT and ALP values were within normal limits. 
Magnetic resonance (MR) imaging was obtained for further evaluation. A side-to-side 
portosystemic shunt between the inferior vena cava (IVC) and the intrahepatic portal vein was 
seen on serial post-contrast MR images (Figure 1 and 2). With these findings, the patient was 
diagnosed with type 2 Abernethy malformation, which was characterized by the absence of 
part of the portal vein with congenital portocaval shunt. 
The patient was followed up with conservative treatment. At the 6-month follow-up 
examination, the patient was asymptomatic. If hepatic encephalopathy develops in the future, 
it is planned to evaluate surgical closure of the shunt. 
 
DISCUSSION 
The portal vein system develops as a result of the selective apoptosis of a portion of 
the vitelline veins at 4-10 weeks of embryonic life. IVC development also coincides, so there 
is potential for congenital portosystemic shunt development [4]. There are two types of 
portosystemic shunt anomalies. In type 1 shunts, there is no intrahepatic portal vein and there 
is a complete end-to-side shunt. Type 1 shunts have two subtypes; type 1a shunts discharge 
separately into the superior mesenteric vein (SMV) and splenic vein (SV), inferior vena cava 
(IVC), iliac veins or renal veins. In type 1b shunts, the SMV and SV converge to form a short 
extrahepatic portal vein. In type 2 shunts, there is a partial side-to-side shunt between the 
intrahepatic portal vein and portal vein. Portoportal collaterals develop when portal vein 
occlusion develops. Type 1 anomaly is more common [5]. The current patient was determined 
with type 2 anomaly.   
Intrahepatic portosystemic shunts are classified by Park et al. [6] in 4 different types. 
In the first and most common type, the right portal vein is connected to the IVC through a 
large vessel. The second type has peripheral shunts in a single hepatic segment. In the third 
type, the shunt is provided with an aneurysm. The fourth type includes peripheral shunts in 
multiple hepatic segments. Persistent ductus venosus can also be evaluated as the fifth type. 
Congenital extrahepatic portosystemic shunts are frequently seen with congenital heart 
disease, polysplenia, biliary atresia, malrotation, duodenal atresia, annular pancreas, situs 
inversus, urinary tract anomalies and skeletal anomalies [7]. However, no additional anomaly 
was present in the current patient. Congenital extrahepatic portosystemic shunts are also 
associated with benign (focal nodular hyperplasia, hepatocellular adenoma, or nodular 
regenerative hyperplasia) or malignant (hepatocellular carcinoma or hepatoblastoma) liver 
neoplasms [8, 9]. It has been suggested that the presence of hepatotropic substances such as 
insulin and glucagon in the splanchnic venous blood outside the liver may cause changes in 
the liver's development, function and regeneration capacity. This deviation and associated 
increase in arterial hepatic flow can lead to neoplasm formation [8]. An imbalance between 
the hepatic artery and the portal vein is thought to pave the way for the development of 
neoplastic tumors [10]. In addition, β-catenin gene mutations leading to tumor development 
have been demonstrated in a patient with Abernethy malformation [11]. In this context, it is 
important to monitor these patients for a long time because of the potential for benign 
formations to develop into malignant tumors [12].  
Patients with Abernethy malformation may also have other symptoms, such as 
intravenous intrapulmonary dilatation and hepatopulmonary syndrome, which may occur due 
to hepatic encephalopathy or vasoactive mediators in systemic circulation as a result of the 
toxicity level of toxins produced in the intestines [13]. In the current patient, there was a mild 
mental fog at the time of admission. 
The diagnosis of Abernethy malformation is currently usually made with imaging 
methods, such as ultrasound, CT or MRI showing shunt and intrahepatic portal vein branches. 
Doppler ultrasonography is a safe and non-invasive method for the diagnosis of intrahepatic 
vasculature, as the amount and direction of flow can be shown. However, it may not be able 
to detect associated anomalies, and the retroperitoneum cannot be well evaluated, especially 
in adult patients. Therefore, smaller shunts, in particular Type 1a, may not be clearly visible. 
Ultrasound may not be able to fully identify liver lesions seen in these patients. Associated 
anomalies and findings, especially lung and cardiac anomalies, will not be defined on 
ultrasound [14, 15]. Computed tomography (CT) is a rapid non-invasive method that 
demonstrates the anatomy and pathology in detail with spatial resolution. The greatest 
advantage of CT is that the portal anomaly and shunt type can be clearly visualized, which 
helps in treatment decision-making. CT evaluates the associated anomalies in patients with 
congenital heart disease who require the assessment of pulmonary vessels, or in patients with 
suspected hepatopulmonary syndrome, which require evaluation of the lungs. However, a 
very significant disadvantage is the radiation dose, which should be taken into consideration 
especially in pediatric patients [3, 16]. MRI, not only has the features of CT, but also helps 
detect and characterize the hepatic lesions in these patients. The use of liver-specific contrast 
agents in the characterization of hepatic nodules is very helpful in the diagnosis. The most 
important superiority of MRI to CT is that it does not expose patients to ionizing radiation. 
MRI is the method that should be used for serial monitoring of hepatic lesions [17, 18]. 
The prognosis depends on the location of congenital heart disease, liver disease, and 
portosystemic shunt. In patients with type 1 malformation, mesenteric venous blood is 
shunted in a single drainage pathway, and surgical closure is not performed in these patients. 
These patients should be followed up clinically and biochemically, and those with hepatic 
encephalopathy and malignant liver nodules should be evaluated for liver transplantation. If a 
serious complication such as hepatic encephalopathy develops in type 2 malformation, the 
shunt may be closed surgically or percutaneously [19]. 
 
CONCLUSIONS 
In conclusion, although Abernethy malformation is quite rare, it can cause serious 
complications, so early recognition is important for the implementation of proper follow-up 
and treatment to avoid complications. 
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FIGURE LEGENDS 
Figure 1. Coronal T2-weighted MR images showing a side-to-side portosystemic shunt 
(arrow) between the IVC (black asterix) and intrahepatic portal vein (white asterix).  
 
Figure 2. Axial postcontrast MR images showing hepatic veins (black arrows) draining into 
IVC (asterix) and a side-to-side portosystemic shunt (white arrow) between the IVC and 
intrahepatic portal vein.  
 


